{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:43:47Z","timestamp":1789155827389,"version":"build-2803163510"},"reference-count":40,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Placenta accreta spectrum (PAS) disorders are a continuum of placental pathologies with increased risk for hemorrhage, blood transfusion and maternal morbidity. Uterine artery embolization (UAE) is a safe approach to the standardization of complex PAS cases. The aim of this study is to analyze anemia and transfusion rate, outcome and anesthesiological management of women who underwent caesarean delivery with subsequent UAE for the management of PAS. Material and Methods: This retrospective observational study included all pregnant women admitted to the University Hospital Frankfurt between January 2012 and September 2023, with a diagnosis of PAS who underwent a two-step surgical approach for delivery and placenta removal. Primary procedure included cesarean delivery with subsequent UAE, secondary procedure included placenta removal after a minim of five weeks via curettage or HE. Maternal characteristics, anesthesiological management, complications, anemia rate, blood loss and administration of blood products were analyzed. Results: In total, 17 women with PAS were included in this study. Of these, 5.9% had placenta increta and 94.1% had placenta percreta. Median blood loss was 300 (200\u2013600) mL during primary procedure and 3600 (450\u20135500) mL during secondary procedure. In total, 11.8% and 62.5% of women received red blood cell transfusion during the primary and secondary procedures, respectively. After primary procedure, postpartum anemia rate was 76.5%. The HE rate was 64.7%. Regional anesthesia was used in 88.2% during primary procedure. Conclusion: The embolization of the uterine artery for women diagnosed with PAS is safe. Anemia management and the implementation of blood conservation strategies are crucial in women undergoing UAE for the management of PAS.<\/jats:p>","DOI":"10.3390\/jcm13041062","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T04:18:22Z","timestamp":1707884302000},"page":"1062","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Management and Outcome of Women with Placenta Accreta Spectrum and Treatment with Uterine Artery Embolization"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1793-2918","authenticated-orcid":false,"given":"Vanessa","family":"Neef","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2886-8947","authenticated-orcid":false,"given":"Armin N.","family":"Flinspach","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Eichler","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, University Hospital, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1189-392X","authenticated-orcid":false,"given":"Tirza R.","family":"Woebbecke","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6755-0539","authenticated-orcid":false,"given":"Stephanie","family":"Noone","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6890-3239","authenticated-orcid":false,"given":"Jan A.","family":"Kloka","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6919-9394","authenticated-orcid":false,"given":"Lukas","family":"Jennewein","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Perinatal Medicine, University Hospital, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2320-3313","authenticated-orcid":false,"given":"Frank","family":"Louwen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Perinatal Medicine, University Hospital, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0212-9110","authenticated-orcid":false,"given":"Kai","family":"Zacharowski","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6597-9585","authenticated-orcid":false,"given":"Florian J.","family":"Raimann","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMcp1709324","article-title":"Placenta Accreta Spectrum","volume":"378","author":"Silver","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.ajog.2004.12.074","article-title":"Abnormal placentation: Twenty-year analysis","volume":"192","author":"Wu","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/GCO.0000000000000773","article-title":"Prenatal diagnosis of placenta accreta spectrum","volume":"34","author":"Conturie","year":"2022","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"218.e1","DOI":"10.1016\/j.ajog.2014.08.019","article-title":"Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach","volume":"212","author":"Shamshirsaz","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.bpobgyn.2008.08.003","article-title":"Diagnosis and management of placenta accreta","volume":"22","year":"2008","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: A WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet. Glob. Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"38.e1","DOI":"10.1016\/j.ajog.2011.01.040","article-title":"Predictors of massive blood loss in women with placenta accreta","volume":"205","author":"Wright","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/AOG.0000000000004976","article-title":"Red Blood Cell Transfusion in Patients With Placenta Accreta Spectrum: A Systematic Review and Meta-analysis","volume":"141","author":"Miller","year":"2023","journal-title":"Obstet. Gynecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1055\/s-0042-1754321","article-title":"Transfusion Requirements with Hybrid Management of Placenta Accreta Spectrum Incorporating Targeted Embolization and a Selective Use of Delayed Hysterectomy","volume":"29","author":"Gatta","year":"2022","journal-title":"Am. J. Perinatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/aogs.12222","article-title":"Management of placenta accreta","volume":"92","author":"Sentilhes","year":"2013","journal-title":"Acta Obstet. Et Gynecol. Scand."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/a-0582-0122","article-title":"Peripartum Haemorrhage, Diagnosis and Therapy. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No.\u2009015\/063, March 2016)","volume":"78","author":"Schlembach","year":"2018","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine (2018). Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Obstet. Gynecol., 132, e259\u2013e275.","DOI":"10.1097\/AOG.0000000000002983"},{"key":"ref_13","first-page":"e1","article-title":"Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a","volume":"126","author":"Jauniaux","year":"2019","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ogc.2015.01.014","article-title":"Placenta accreta spectrum: Accreta, increta, and percreta","volume":"42","author":"Silver","year":"2015","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/AOG.0b013e3182051db2","article-title":"Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care","volume":"117","author":"Eller","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"612.e1","DOI":"10.1016\/j.ajog.2017.02.016","article-title":"Multidisciplinary team learning in the management of the morbidly adherent placenta: Outcome improvements over time","volume":"216","author":"Shamshirsaz","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1080\/14767058.2019.1676411","article-title":"Assessing the multidisciplinary team approaches to placenta accreta spectrum across five institutions within the University of California fetal Consortium (UCfC)","volume":"34","author":"Fratto","year":"2021","journal-title":"J. Matern.-Fetal Neonatal Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"442.e1","DOI":"10.1016\/j.ajog.2021.07.001","article-title":"Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: The PASTIME protocol","volume":"225","author":"Melber","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.jvir.2023.07.020","article-title":"Prophylactic Uterine Artery Embolization in Placenta Accreta Spectrum-An Active Intervention to Reduce Morbidity and Promote Uterine Preservation","volume":"34","author":"Sebastian","year":"2023","journal-title":"J. Vasc. Interv. Radiol. JVIR"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00270-021-02921-2","article-title":"Prophylactic Intraoperative Uterine Artery Embolization During Cesarean Section or Cesarean Hysterectomy in Patients with Abnormal Placentation: A Systematic Review and Meta-Analysis","volume":"45","author":"Yang","year":"2022","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"General Assembly of the World Medical Association (2013). World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. Jama, 310, 2191\u20132194.","DOI":"10.1001\/jama.2013.281053"},{"key":"ref_22","unstructured":"World Health Organization (WHO) (2024, February 08). Anaemia. Available online: https:\/\/www.who.int\/data\/nutrition\/nlis\/info\/anaemia."},{"key":"ref_23","unstructured":"(2024, February 08). Bundes\u00e4rztekammer. Querschnitts-Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. Available online: https:\/\/www.bundesaerztekammer.de\/fileadmin\/user_upload\/_old-files\/downloads\/pdf-Ordner\/MuE\/Querschnitts-Leitlinien_BAEK_zur_Therapie_mit_Blutkomponenten_und_Plasmaderivaten-Gesamtnovelle_2020.pdf."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ijgo.12409","article-title":"FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management","volume":"140","author":"Allen","year":"2018","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-0030-1247599","article-title":"Prophylactic pelvic artery catheterization and embolization in women with placenta accreta: Can it prevent cesarean hysterectomy?","volume":"27","author":"Sivan","year":"2010","journal-title":"Am. J. Perinatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/GCO.0b013e32834cef7a","article-title":"The morbidly adherent placenta: Diagnosis and management options","volume":"23","author":"Hayes","year":"2011","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"61.e1","DOI":"10.1016\/j.ajog.2023.03.028","article-title":"Implementation and outcomes of a uterine artery embolization and tranexamic acid protocol for placenta accreta spectrum","volume":"229","author":"Munoz","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/aogs.13868","article-title":"Cesarean delivery with and without uterine artery embolization for the management of placenta accreta spectrum disorder-A comparative study","volume":"99","author":"Hochman","year":"2020","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.ajog.2009.08.040","article-title":"Placenta percreta: Urologic complication after successful conservative management by uterine arterial embolization: A case report","volume":"201","author":"Diop","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1514.e3","DOI":"10.1016\/j.fertnstert.2006.02.128","article-title":"Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies","volume":"86","author":"Alanis","year":"2006","journal-title":"Fertil. Steril."},{"key":"ref_31","first-page":"37","article-title":"Anemia, red blood cell transfusion and administration of blood products in obstetrics: A nationwide analysis of more than 6 million cases from 2011\u20132020","volume":"22","author":"Kloka","year":"2023","journal-title":"Blood Transfus."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/ACO.0000000000001252","article-title":"Current concepts in preoperative anemia management in obstetrics","volume":"36","author":"Wiesenack","year":"2023","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00277-011-1279-z","article-title":"Postpartum anemia I: Definition, prevalence, causes, and consequences","volume":"90","author":"Milman","year":"2011","journal-title":"Ann. Hematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/tme.12443","article-title":"Patient blood management in obstetrics: Management of anaemia and haematinic deficiencies in pregnancy and in the post-partum period: NATA consensus statement","volume":"28","author":"Robinson","year":"2018","journal-title":"Transfus. Med."},{"key":"ref_35","unstructured":"(2024, February 08). NICE. Antenatal Care. Available online: https:\/\/www.nice.org.uk\/guidance\/ng201\/resources\/antenatal-care-pdf-66143709695941."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/anae.14331","article-title":"Association of Anaesthetists guidelines: Cell salvage for peri-operative blood conservation 2018","volume":"73","author":"Klein","year":"2018","journal-title":"Anaesthesia"},{"key":"ref_37","first-page":"112","article-title":"Patient blood management in obstetrics: Prevention and treatment of postpartum haemorrhage. A NATA consensus statement","volume":"17","author":"Stensballe","year":"2019","journal-title":"Blood Transfus. Trasfus. Sangue"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJMoa2207419","article-title":"Tranexamic Acid to Prevent Obstetrical Hemorrhage after Cesarean Delivery","volume":"388","author":"Pacheco","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Neef, V., Friedrichson, B., Jasny, T., Old, O., Raimann, F.J., Choorapoikayil, S., Steinbicker, A.U., Meybohm, P., Zacharowski, K., and Kloka, J.A. (Br. J. Anaesth., 2024). Use of cell salvage in obstetrics in Germany: Analysis of national database of 305 610 cases with peripartum haemorrhage, Br. J. Anaesth., ahead of print.","DOI":"10.1016\/j.bja.2023.12.014"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1399-6576.2005.00804.x","article-title":"Inhibitory effects of desflurane and sevoflurane on oxytocin-induced contractions of isolated pregnant human myometrium","volume":"49","author":"Yildiz","year":"2005","journal-title":"Acta Anaesthesiol. Scand."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/4\/1062\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:59:23Z","timestamp":1760104763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/4\/1062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,13]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["jcm13041062"],"URL":"https:\/\/doi.org\/10.3390\/jcm13041062","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,13]]}}}